CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,278,223 | +100.7% | 24,743 | -3.7% | 0.00% | – |
| Q2 2022 | $636,995 | +12.2% | 25,706 | +13.6% | 0.00% | – |
| Q1 2022 | $567,510 | -43.7% | 22,637 | -18.2% | 0.00% | -100.0% |
| Q4 2021 | $1,008,000 | +102.8% | 27,680 | -4.7% | 0.00% | – |
| Q3 2021 | $497,000 | +17.8% | 29,048 | -7.9% | 0.00% | – |
| Q2 2021 | $422,000 | -70.7% | 31,550 | +12.4% | 0.00% | -100.0% |
| Q1 2021 | $1,438,000 | -22.1% | 28,072 | -5.9% | 0.00% | -50.0% |
| Q4 2020 | $1,847,000 | +18.0% | 29,823 | +4.4% | 0.00% | 0.0% |
| Q3 2020 | $1,565,000 | +7.0% | 28,558 | +6.9% | 0.00% | +100.0% |
| Q2 2020 | $1,462,000 | +38.6% | 26,717 | +1.8% | 0.00% | 0.0% |
| Q1 2020 | $1,055,000 | +4.6% | 26,247 | +2.9% | 0.00% | 0.0% |
| Q4 2019 | $1,009,000 | +476.6% | 25,515 | -4.4% | 0.00% | – |
| Q3 2019 | $175,000 | -29.4% | 26,683 | 0.0% | 0.00% | – |
| Q2 2019 | $248,000 | +3.3% | 26,683 | +46.5% | 0.00% | – |
| Q2 2018 | $240,000 | -13.0% | 18,218 | -10.5% | 0.00% | – |
| Q1 2018 | $276,000 | +452.0% | 20,352 | +140.9% | 0.00% | – |
| Q4 2017 | $50,000 | -68.6% | 8,450 | -60.6% | 0.00% | – |
| Q3 2017 | $159,000 | -24.6% | 21,437 | -4.8% | 0.00% | – |
| Q2 2017 | $211,000 | +46.5% | 22,514 | +14.5% | 0.00% | – |
| Q1 2017 | $144,000 | +8.3% | 19,662 | +9.6% | 0.00% | – |
| Q4 2016 | $133,000 | +1562.5% | 17,944 | +1240.1% | 0.00% | – |
| Q3 2016 | $8,000 | +33.3% | 1,339 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | -87.8% | 1,339 | -93.7% | 0.00% | – |
| Q1 2016 | $49,000 | -67.8% | 21,091 | +12.3% | 0.00% | – |
| Q4 2015 | $152,000 | +34.5% | 18,789 | 0.0% | 0.00% | – |
| Q3 2015 | $113,000 | -27.1% | 18,789 | 0.0% | 0.00% | – |
| Q2 2015 | $155,000 | +6.2% | 18,789 | -3.4% | 0.00% | – |
| Q1 2015 | $146,000 | +82.5% | 19,449 | +67.9% | 0.00% | – |
| Q4 2014 | $80,000 | -5.9% | 11,586 | -38.6% | 0.00% | – |
| Q3 2014 | $85,000 | +80.9% | 18,884 | +135.2% | 0.00% | – |
| Q2 2014 | $47,000 | -65.9% | 8,029 | -61.2% | 0.00% | – |
| Q1 2014 | $138,000 | +15.0% | 20,699 | 0.0% | 0.00% | – |
| Q4 2013 | $120,000 | +11.1% | 20,699 | +6.3% | 0.00% | – |
| Q3 2013 | $108,000 | -59.4% | 19,472 | +3.5% | 0.00% | -100.0% |
| Q2 2013 | $266,000 | – | 18,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |